HopeStageGet research updates
HopeStage
hi@hopestage.com

Built by people with lived experience, between Sydney and Paris.

Back to all studies
CompletedNCT01518634

Imipramine Treatment for people with Multi-organ Bodily Distress Syndrome

It focuses on somatic symptom disorders and currently lists study information in Denmark.

Somatic symptom disorders, Somatic symptom disorders, ...DrugFrom 20 Years to 50 Years
The study in practice

Understand this study

Who was this study for?

Listed age limits: 20 years to 50 years.

Listed locations
Aarhus, DenmarkSee all locations and recruitment

Compensation and expense reimbursement have not been verified for this summary.

Study clarity

Study information

Study start dateJanuary 2012
Recruitment status
Completed
Enrollment listed in the registry
138
Sponsor
University of Aarhus
Sponsor type
University
Study type
Drug
Intervention type
Medication / drug
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Locations
Denmark
Age range
From 20 Years to 50 Years
Official registry ID
NCT01518634
Official title
Treatment of Multi-organ Bodily Distress Syndrome. A Double-blinded Placebo Controlled Trial of the Effects of Imipramine (Stress-3)

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Aarhus

Checked Official study record (opens in a new tab)
Registry details
Registry conditions (original wording)

Somatisation Disorder; Somatoform Disorders

FAQ

Questions about this study

Who is behind this study?

The study sponsor is University of Aarhus, a university.

Did this study involve medication?

Yes. The study involved medication, including Imipramine treatment and Placebo.

Who was this study for?

Listed age limits: 20 years to 50 years.

Explore other studies

Want to find a study that may fit you better?

Answer a few simple questions to explore HopeStage studies by condition, country, and situation.

Find a study that may fit me
Related studies

Explore related studies

Other studies that may be relevant based on condition, country, or study type.

Drug study icon
CompletedEUCTR 2011-004294-87

Treatment of multi-organ bodily distress syndrome. A double-blinded placebo controlled trial of the effect of Imipramine (STreSS-3) Behandling af multi-organ bodily distress syndrome. Et dobbelt-blindet placebokontrolleret forsøg af effekten af Imipramin (STreSS-3)

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments. Check the source details below for country statuses and any transfer to CTIS.